Literature DB >> 9255204

Toxic shock syndrome without rash in a young child: link with syndrome of hemorrhagic shock and encephalopathy?

S Van Lierde1, W J van Leeuwen, J Ceuppens, L Cornette, P Goubau, J Van Eldere.   

Abstract

A diffuse macular erythroderma and subsequent desquamation after 1 to 2 weeks are two of the five major diagnostic criteria of toxic shock syndrome (TSS). We present the case of a 15-month-old girl with TSS, but without erythroderma or desquamation. She was admitted with high fever, shock, and multiorgan involvement. Minimal or no cutaneous signs were present. Initially the diagnosis of the syndrome of hemorrhagic shock and encephalopathy was made. After 7 days, a TSS toxin 1-producing strain of Staphylococcus aureus was cultured from an inguinal lymph node, where inflammation had already been noticed on admission. Moreover, the girl had no antibodies against this toxin. The serum cytokine profile during the acute phase of her illness showed high levels of tumor necrosis factor-alpha, interleukin-6 and interferon-gamma, as is seen during activation of the immune system by TSS toxin 1. Other possible causes for the patient's illness were excluded. We conclude that the patient had TSS without rash. Without the evidence implicating a TSS toxin 1-producing strain of S. aureus as the cause of her disease, a diagnosis of syndrome of hemorrhagic shock and encephalopathy would have been made. It is possible that some cases of syndrome of hemorrhagic shock and encephalopathy represent a variant of TSS in small children.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255204     DOI: 10.1016/s0022-3476(97)70136-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology.

Authors:  Peter A Szabo; Ankur Goswami; Delfina M Mazzuca; Kyoungok Kim; David B O'Gorman; David A Hess; Ian D Welch; Howard A Young; Bhagirath Singh; John K McCormick; S M Mansour Haeryfar
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

2.  Lack of muco-cutaneous signs of toxic shock syndrome when T cells are absent: S. aureus shock in immunodeficient adults with multiple myeloma.

Authors:  N S Kamel; M C Banks; A Dosik; D Ursea; A A Yarilina; D N Posnett
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

Review 3.  Toxic shock syndrome in children: epidemiology, pathogenesis, and management.

Authors:  Yu-Yu Chuang; Yhu-Chering Huang; Tzou-Yien Lin
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

4.  Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity.

Authors:  Chandy C John; Micah Niermann; Bazak Sharon; Marnie L Peterson; David M Kranz; Patrick M Schlievert
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.